Correlation Between Hashimoto's Thyroiditis and Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Nov 17

PMID 36387911

Authors

Xiaojie Hu

Yuquan Chen

Yiting Shen

Siyuan Zhou

Wenting Fei

Yuxin Yang

Huafa Que

Affiliations

Soon will be listed here.

Abstract

Objective: A growing body of research suggests that patients with polycystic ovary syndrome (PCOS) may be at increased risk of developing Hashimoto's thyroiditis (HT), and having both conditions can make the condition worse. However, current research views are not uniform. Therefore, to explore the link between PCOS and HT, we conducted this study.

Methods: From the establishment of the database to August 2022, we searched 2 databases to study the correlation between Hashimoto's and polycystic ovary syndrome. Two authors independently screened the articles for eligibility, and three authors extracted relevant data. Statistical analysis was performed using STATA16.0 software.

Results: A total of 20 studies were included, including 7 case-control studies and 13 cross-sectional studies. A total of 13 countries and 7857 participants were embraced. Studies have demonstrated that both PCOS patients have an increased risk of HT, and meanwhile, HT patients also have an increased risk of PCOS compared with controls. The study also incorporated that the prevalence of HT in PCOS patients in India and Turkey was higher than in other countries, and the prevalence of HT in PCOS patients in South America was higher than in Asia and Europe.

Conclusions: In conclusion, our study illustrates that there is a correlation between PCOS and HT, and it is necessary to further study the underlying mechanism between PCOS and HT. At the same time, it is of great significance to regularly screen PCOS patients for HT risk and HT patients for PCOS risk.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD 42022351168.

Citing Articles

Unveiling the link: anti-protein disulfide isomerase A3 autoantibody expression and polycystic ovary syndrome risk in euthyroid autoimmune thyroiditis women.

Chen Z, Zhang C, Meng C, Hu Y, Niu Y, Gao B J Ovarian Res. 2024; 17(1):247.

PMID: 39702372 PMC: 11656784. DOI: 10.1186/s13048-024-01569-z.

The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis-Review.

Cyna W, Wojciechowska A, Szybiak-Skora W, Lacka K Biomedicines. 2024; 12(8).

PMID: 39200253 PMC: 11351723. DOI: 10.3390/biomedicines12081788.

Impact of thyroid autoimmunity on the cumulative live birth rates after IVF/ICSI treatment cycles.

Huang N, Chen L, Yan Z, Chi H, Qiao J BMC Pregnancy Childbirth. 2024; 24(1):230.

PMID: 38566020 PMC: 10985846. DOI: 10.1186/s12884-024-06411-4.

About Polycystic Ovary Syndrome and Thyroid Dysfunctions: Can Inherent Particulars of Same‑Sex Sexual Orientation Go Missing?.

Sabuncuoglu O Arch Sex Behav. 2023; 52(8):3177-3179.

PMID: 37730919 DOI: 10.1007/s10508-023-02696-2.

Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature.

Palomba S, Colombo C, Busnelli A, Caserta D, Vitale G Front Endocrinol (Lausanne). 2023; 14:1251866.

PMID: 37635968 PMC: 10453810. DOI: 10.3389/fendo.2023.1251866.

References

Rajashekar L, Krishna D, Patil M . Polycystic ovaries and infertility: Our experience. J Hum Reprod Sci. 2009; 1(2):65-72. PMC: 2700664. DOI: 10.4103/0974-1208.44113. View

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

Lee H, Li C, Hammerstad S, Stefan M, Tomer Y . Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun. 2015; 64:82-90. PMC: 4628844. DOI: 10.1016/j.jaut.2015.07.009. View

Petrikova J, Figurova J, Dravecka I, Lazurova I . [Is polycystic ovary syndrome associated with autoimmune thyroiditis?]. Vnitr Lek. 2012; 58(11):830-3. View

Arora S, Sinha K, Kolte S, Mandal A . Endocrinal and autoimmune linkage: Evidences from a controlled study of subjects with polycystic ovarian syndrome. J Hum Reprod Sci. 2016; 9(1):18-22. PMC: 4817282. DOI: 10.4103/0974-1208.178636. View

Al-Saab R, Haddad S . Detection of thyroid autoimmunity markers in euthyroid women with polycystic ovary syndrome: a case-control study from syria. Int J Endocrinol Metab. 2014; 12(3):e17954. PMC: 4166006. DOI: 10.5812/ijem.17954. View

Kim J, Yoon J, Kim M, Kim S, Hwang K, Choi Y . Thyroid autoimmunity markers in women with polycystic ovary syndrome and controls. Hum Fertil (Camb). 2020; 25(1):128-134. DOI: 10.1080/14647273.2019.1709668. View

Petrikova J, Lazurova I, Dravecka I, Vrbikova J, Kozakova D, Figurova J . The prevalence of non organ specific and thyroid autoimmunity in patients with polycystic ovary syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014; 159(2):302-6. DOI: 10.5507/bp.2014.062. View

Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C, Hefler L . Serologic markers of autoimmunity in women with polycystic ovary syndrome. Fertil Steril. 2009; 93(7):2291-4. DOI: 10.1016/j.fertnstert.2009.01.056. View

10.

Calvar C, Bengolea S, Deutsch S, Hermes R, Ramos G, Loyato M . [High frequency of thyroid abnormalities in polycystic ovary syndrome]. Medicina (B Aires). 2015; 75(4):213-7. View

11.

Macklon N . Polycystic ovary syndrome. BMJ. 2011; 343:d6407. DOI: 10.1136/bmj.d6407. View

12.

Ganie M, Marwaha R, Aggarwal R, Singh S . High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case-control study. Eur J Endocrinol. 2010; 162(6):1117-22. DOI: 10.1530/EJE-09-1012. View

13.

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

14.

Brix T, Ferlov-Schwensen C, Thvilum M, Hegedus L . Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto's thyroiditis. A nationwide Danish register study. Endocrine. 2019; 65(3):616-622. DOI: 10.1007/s12020-019-01946-5. View

15.

Skrzynska K, Zachurzok A, Tomaszewski R, Gawlik A, Malecka-Tendera E . The prevalence of autoimmune thyroiditis in adolescent girls with polycystic ovary syndrome. Ginekol Pol. 2022; 93(12):948-953. DOI: 10.5603/GP.a2021.0238. View

16.

Caturegli P, De Remigis A, Rose N . Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014; 13(4-5):391-7. DOI: 10.1016/j.autrev.2014.01.007. View

17.

Zhai Y, Pang Y . Systemic and ovarian inflammation in women with polycystic ovary syndrome. J Reprod Immunol. 2022; 151:103628. DOI: 10.1016/j.jri.2022.103628. View

18.

Tilg H, Moschen A . Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008; 14(3-4):222-31. PMC: 2215762. DOI: 10.2119/2007-00119.Tilg. View

19.

Gaberscek S, Zaletel K, Schwetz V, Pieber T, Obermayer-Pietsch B, Lerchbaum E . Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur J Endocrinol. 2014; 172(1):R9-21. DOI: 10.1530/EJE-14-0295. View

20.

Wild R, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale H, Futterweit W . Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010; 95(5):2038-49. DOI: 10.1210/jc.2009-2724. View